RxRevu Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- RxRevu's estimated annual revenue is currently $4.8M per year.
- RxRevu received $3.0M in venture funding in March 2016.
- RxRevu's estimated revenue per employee is $120,000
- RxRevu's total funding is $10.1M.
- RxRevu has 40 Employees.
- RxRevu grew their employee count by 14% last year.
- RxRevu currently has 2 job openings.
|Kyle Kiser||President and Chief Strategy Officer|
|Nic Kostman||Vice President of Operations|
|Jacqueline Kostelec||Account Director|
|Benton Barney||SVP, Business Development|
|Weston Blakeslee||Chief Clinical Officer|
|Dennis Blair||Director of Payer/PBM Engagement|
|AARON CORNELL||Chief Financial Officer|
|Trent Kriete||Chief Data Scientist & Dir Engineering|
|Jade Perkins||Account Director|
|Lori Murphy||Director of Provider Growth|
What Is RxRevu?
Drive Informed, Consistent and Measurable Prescription Decisions with RxRevu. RxRevu has emerged from the need to deliver more consistent, cost-effective prescribing to patients. Providers and payers are under more pressure than ever to collaborate to increase the value of the care they deliver, but key information is missing at the point of care. RxRevu is Prescription Decision Support. Our SwiftRx platform leverages prescription decision support to provide prescribers with real-time, patient-specific cost information and alternatives at the point of care to help them make more informed and consistent prescribing decisions. That's why Business Insider referred to us as "The Google of Drugs." Contact us for a product demo to see how we can help your organization.keywords:Healthcare,Healthcare Providers,Human Resources Hr,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Amazing Care Ho...||$13M||71||25%||N/A|
DENVER, June 4, 2019 /PRNewswire/ -- RxRevu, the industry leader in Prescription Decision Support, has closed its Series A funding round ...
Colorado-based startup RxRevu, which specializes in using machine learning for prescription decision support, has landed $15.9 million in ...
RxRevu, a Denver, Colorado-based company focused on prescription decision support, has wrapped up a $15.9 million Series A funding ...
|2016-03-04||$3.0M||Undisclosed||Summation Health Ventures||Article|